These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6644793)

  • 1. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
    Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
    J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients.
    Velardi A; Spinozzi F; Rambotti P; Tabilio A; Losito A; Zampi I; Cernetti C; Martelli MF; Grignani F; Davis S
    J Clin Oncol; 1983 Feb; 1(2):117-25. PubMed ID: 6668495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of splenectomy on the levels of circulating immune complexes (CIC) in Hodgkin's disease (HD).
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1987; 34(1):89-93. PubMed ID: 3561608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
    Brandeis WE; Tan C; Wang Y; Good RA; Day NK
    Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Appearance of circulating immune complexes in patients with Hodgkin's disease and the etiology of this disease].
    Dziewulska-Bokiniec A; Sztaba-Kania M
    Wiad Lek; 1992 Oct; 45(19-20):740-3. PubMed ID: 1296377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J; Levanon M; Davidsohn J; Ramot B
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in Hodgkin's disease.
    Akolkar PN; Advani SH; Gothoskar BP
    Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
    Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
    Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
    Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
    J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some immunological parameters in Hodgkin's disease.
    Dienstbier Z; Hermanská Z; Pĕnicka P; Zámecník J
    Neoplasma; 1988; 35(1):51-60. PubMed ID: 3352837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in sarcoidosis.
    Selroos O; Klockars M; Kekomäki R; Pentinen K; Lindström P; Wager O
    J Clin Lab Immunol; 1980 Mar; 3(2):129-32. PubMed ID: 6259356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages.
    Lappin D; Hamilton AD; Morrison L; Aref M; Whaley K
    J Clin Lab Immunol; 1986 Jul; 20(3):101-5. PubMed ID: 3638367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Tomasević Z; Jelić S
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
    Fisher RI; Bostick-Bruton F
    J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
    Shiftan TA; Caviles AP; Mendelsohn J
    Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc status and cellular immunity in pediatric Hodgkin's disease.
    Cavdar AO; Babacan E; Ertem U; Gözdasoğlu S; Arcasoy A
    Prog Clin Biol Res; 1983; 129():207-20. PubMed ID: 6657703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune deficiency in Hodgkin and non-Hodgkin lymphoma.
    El-Haddad SI; El-Ashmawy S; Hassan W; George E; Ali FM; Sharaf MA; Mahfouz M
    Biomedicine; 1980 Oct; 32(3):128-33. PubMed ID: 7448322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating immune complexes in the serum in Hodgkin's disease].
    Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
    Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte function in Hodgkin's disease.
    Holm G; Björkholm M; Johansson B; Mellstedt H; Lindemalm C
    Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.